Circulating Tumor Cells-driven Choice of First Line Therapy for ER+HER2-metastatic Breast Cancer: Overall Survival Analysis of the Randomized STIC CTC Trial
CANCER RESEARCH（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined